Mark Pieterse

2.6k total citations
6 papers, 565 citations indexed

About

Mark Pieterse is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Mark Pieterse has authored 6 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Mark Pieterse's work include BRCA gene mutations in cancer (3 papers), DNA Repair Mechanisms (3 papers) and Cancer Genomics and Diagnostics (2 papers). Mark Pieterse is often cited by papers focused on BRCA gene mutations in cancer (3 papers), DNA Repair Mechanisms (3 papers) and Cancer Genomics and Diagnostics (2 papers). Mark Pieterse collaborates with scholars based in Netherlands and United Kingdom. Mark Pieterse's co-authors include Jos Jonkers, Hanneke van der Gulden, Peter Bouwman, Christiaan Klijn, Rinske Drost, Ellen Wientjens, Ingrid van der Heijden, Wigard P. Kloosterman, Ute Boon and Peter Green and has published in prestigious journals such as Nature Genetics, Cancer Cell and Cancer Research.

In The Last Decade

Mark Pieterse

6 papers receiving 563 citations

Peers

Countries citing papers authored by Mark Pieterse

Since Specialization

Citations

This map shows the geographic impact of Mark Pieterse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pieterse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pieterse more than expected).

Fields of papers citing papers by Mark Pieterse

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pieterse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pieterse. The network helps show where Mark Pieterse may publish in the future.

Co-authorship network of co-authors of Mark Pieterse

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pieterse. A scholar is included among the top collaborators of Mark Pieterse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pieterse. Mark Pieterse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	Enhancer hubs and loop collisions identified from single-allele topologies 2018 ·Nature Genetics ·Amin Allahyar, Carlo Vermeulen, Britta A. M. Bouwman, Peter H.L. Krijger, Marjon J.A.M. Verstegen, Geert Geeven, Melissa van Kranenburg, Mark Pieterse, Roy Straver, Judith H.I. Haarhuis, Kees Jalink, Hans Teunissen, Ivo Renkens, Wigard P. Kloosterman, Benjamin D. Rowland, Elzo de Wit, Jeroen de Ridder, Wouter de Laat	162
2	A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer 2017 ·Cancer Research ·Wigard P. Kloosterman, Robert R.J. Coebergh van den Braak, Mark Pieterse, Markus J. van Roosmalen, Anieta M. Sieuwerts, (unknown), (unknown), Zarina S. Lalmahomed, Salo Ooft, Anne van Galen, Marcel Smid, (unknown), Fried Zwartkruis, John W.M. Martens, John A. Foekens, Katharina Biermann, Marco J. Koudijs, Jan N.M. IJzermans, Emile E. Voest	67
3	Detailed imaging and genetic analysis reveal a secondary BRAF^L^505H resistance mutation and extensive intrapatient heterogeneity in metastatic BRAF mutant melanoma patients treated with vemurafenib 2014 ·Pigment Cell & Melanoma Research ·Marlous Hoogstraat, (unknown), Inge Ubink, Nicolle Besselink, Mark Pieterse, Wouter B. Veldhuis, Marijn van Stralen, Eelco F. J. Meijer, Stefan M. Willems, Michael A. Hadders, Thomas Kuilman, Oscar Krijgsman, Daniel S. Peeper, Marco J. Koudijs, Edwin Cuppen, Emile E. Voest, Martijn P. Lolkema	21
4	A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants 2013 ·Cancer Discovery ·Peter Bouwman, Hanneke van der Gulden, Ingrid van der Heijden, Rinske Drost, Christiaan Klijn, Pramudita R. Prasetyanti, Mark Pieterse, Ellen Wientjens, Jost Seibler, Frans B.L. Hogervorst, Jos Jonkers	92
5	BRCA1 RING Function Is Essential for Tumor Suppression but Dispensable for Therapy Resistance 2011 ·Cancer Cell ·Rinske Drost, Peter Bouwman, Sven Rottenberg, Ute Boon, Eva Schut, Sjoerd Klarenbeek, Christiaan Klijn, Ingrid van der Heijden, Hanneke van der Gulden, Ellen Wientjens, Mark Pieterse, Aurélie Catteau, Peter Green, Ellen Solomon, Joanna R. Morris, Jos Jonkers	197
6	Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression 2011 ·The Journal of Pathology ·Peter Bouwman, Rinske Drost, Christiaan Klijn, Mark Pieterse, Hanneke van der Gulden, Ji‐Ying Song, Károly Szuhai, Jos Jonkers	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact